an online magazine from eyeway.org
an online magazine from eyeway.org
issue 3 
march-april 2005
click here to browse other issues
other sections in this issue: by george | focus | perspectives | profile | feature | review | forum
Headlines : INTERNATIONAL news
other headlines sub-sections: india
news | calendar of events
Drug to combat blindness in the elderly under development
Reuters, January 20, 2005
A private biotechnology company called Angiosyn, Inc., in the United States, is developing a drug for macular degeneration, the leading cause of blindness in the elderly. So far the drug has only been tested in animals.
The U.S. Food and Drug Administration had, in December 2004, approved a drug for the more severe form of macular degeneration that was developed by Pfizer (which is in talks to acquire Angiosyn). Analysts estimate the drug, Macugen, could eventually generate more than $1 billion a year.
Other World News stories in this issue:
Sight Savers helps irreversibly blind children attend
mainstream schools
Scientists regenerate damaged optic nerve
Unite for Sight : Focused on eye care